PA
FNB icon

PharVision Advisers’s FNB Corp FNB Stock Holding History

PharVision Advisers’s Portfolio FNB Stock Details FNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,149
Closed -$208K – 307
2025
Q4 		$208K Buy
+12,149
New +$199K 0.11% 527
2025
Q2 		– Sell
-14,747
Closed -$198K – 331
2025
Q1 		$198K Buy
+14,747
New +$217K 0.28% 202

Other funds holding FNB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's FNB Position: Q1 2026 in Review

PharVision Advisers sold out of FNB Corp (FNB) in Q1 2026, closing a stake of 12,149 shares — an estimated $208K sold.

PharVision Advisers first reported a position in FNB in Q1 2025 and held it in 2 quarters. The position peaked at $208K in Q4 2025. 502 funds tracked by Wall St. Rank hold FNB as of Q1 2026.

  • PharVision Advisers reported no remaining FNB Corp position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,149 FNB Corp shares in Q1 2026, an estimated $208K.
  • PharVision Advisers first reported a position in FNB Corp in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's FNB Corp position peaked at $208K in Q4 2025.
  • 502 funds tracked by Wall St. Rank held FNB Corp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.